3BBLACKBIOUpdated 29 Aug 2026, 10:55

3b Blackbio Dx Ltd.

3BBLACKBIOUpdated 29 Aug 2026, 10:55

Market Cap

₹1,237Cr.

Current Price

₹1,441

High / Low

₹1,750/1,084

Stock P/E

24.3

ROE16.7%

ROCE22.4%

Book Value₹372

Face Value₹10.0

Dividend Yield0.28%

About

Incorporated in 2011, 3B BlackBio Dx Ltd manufactures and exports PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents, and agrochemical-based products[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	271	303	371	332	426	382	358	337	206	188	142	162
Inventory Days	128	121	190	108	176	116	88	81	154	144	122	102
Days Payable	204	190	237	115	156	108	95	108	63	65	24	21
Cash Conversion Cycle	196	234	323	326	447	390	351	311	297	267	240	243
Working Capital Days	183	218	279	328	427	438	422	391	248	225	174	182
ROCE %	6%	5%	6%	6%	4%	4%	9%	34%	32%	22%	26%	22%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 29 August 2026 at 10:55

3B BLACKBIO DX LTD. (3BBLACKBIO) financials — quarterly results, P&L, cash flow, balance sheet, shareholding